Square Pharmaceuticals Ltd. reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was BDT 16,881.36 million compared to BDT 14,792.62 million a year ago. Revenue was BDT 14,650 million compared to BDT 12,770.13 million a year ago. Net income was BDT 4,569.54 million compared to BDT 3,862.06 million a year ago. Basic earnings per share from continuing operations was BDT 5.15 compared to BDT 4.36 a year ago.
For the nine months, sales was BDT 50,731.2 million compared to BDT 43,871.94 million a year ago. Revenue was BDT 43,722.24 million compared to BDT 37,711.77 million a year ago. Net income was BDT 14,210.55 million compared to BDT 11,631.66 million a year ago. Basic earnings per share from continuing operations was BDT 16.03 compared to BDT 13.12 a year ago.